Zobrazeno 1 - 10
of 261
pro vyhledávání: ''
Autor:
Adwoa K. A. Afrane, Seth Agyeman, Yakubu Alhassan, Seth N. Owiafe, Kwamena W. Sagoe, Bamenla Q. Goka, Alfred Yawson, Lorna Renner, Awewura Kwara
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Children living with human immunodeficiency virus (HIV) infection require lifelong effective antiretroviral therapy (ART). The goal of ART in HIV-infected persons is sustained viral suppression. There is limited information on virological
Autor:
Eva Heinz, Janelisa Musaya, Patrick Noah, Nicholas A. Feasey, Vincent Samuel Phiri, Gabriel Kambale Bunduki
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-13 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Uropathogenic Escherichia coli (UPEC) are amongst the most frequent causes of urinary tract infections. We report a systematic review and meta-analysis of virulence factors and antimicrobial resistance of UPEC isolated from urinary tract i
Autor:
Haibo Ding, Lin Wang, Zhen Wang, Minghui An, Bin Zhao, Xiaoxu Han, Lu Wang, Xin Li, Wei Song, Xue Dong, Wen Tian
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background To assess transmitted drug resistance (TDR) to tenofovir (TDF)/emtricitabine (FTC), using as pre-exposure prophylaxis, among newly diagnosed human immunodeficiency virus-1 (HIV-1)-infected residents in Shenyang city, northeast China. Metho
Autor:
Grahame Mtui, Semvua B. Kilonzo, Paulina M. Manyiri, Daniel W. Gunda, Fredrick Kalokola, Elichilia R. Shao, Fatma A. Bakshi, Hyasinta Jaka, Alex Stephano, David C. Majinge
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Methadone therapy clinics have been recently introduced in Tanzania, aiming at reducing risk behaviors and infection rates of viral hepatitis and HIV among people who use drugs. The objective of this study was to estimate the prevalence, a
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Lower respiratory tract infection is a global problem accounting over 50 million deaths annually. Here, we determined the bacterial profile and antimicrobial susceptibility pattern of lower respiratory tract infections among adult patients
Autor:
Tandaogo Saouadogo, Daniela Maria Cirillo, Léon T. Sawadogo, Adjima Combary, Riccardo Alagna, Elisa Tagliani, Francis Ouedraogo, Souba Diandé
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Backgrounds The laboratory plays a critical role in tuberculosis (TB) control by providing testing for diagnosis, treatment monitoring, and surveillance at each level of the health care system. Weak accessibility to TB diagnosric services still repre
Autor:
Edmund Wilkins, Frank Smithuis, Alistair R. D. McLean, Clare E. Warrell, Catriona Macrae, Ni Ni Tun, Elizabeth A. Ashley
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-6 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background Cryptococcal meningitis (CM) is a common HIV-associated opportunistic-infection worldwide. Existing literature focusses on hospital-based outcomes of induction treatment. This paper reviews outpatient management in integrated primary care
Autor:
Maureen Kamene, Sylvia M LaCourse, Daniel Matemo, Zachary Feldman, John Kinuthia, David J. Horne, Jerphason Mecha, Ruanne V. Barnabas, Alex J Warr, Jill K. Gersh
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background People living with HIV (PLHIV) who reside in high tuberculosis burden settings remain at risk for tuberculosis disease despite treatment with anti-retroviral therapy and isoniazid preventive therapy (IPT). The performance of the World Heal
Autor:
Marie Helene Delbouille, Arnaud Ancion, Philippe Amabili, Jean-Olivier Defraigne, Melissa Van den Bulck, Vincent Tchana-Sato, Jean-Paul Lavigne, Philippe Delvenne, Elie Minga Lowampa, Marie-Pierre Hayette, Olivier Hougrand, Delphine Szecel, Isabelle Maquoi, Marc Senard, Charlotte Ponte, Julien Tridetti, Philippe Morimont, Natzi Sakalihasan, Olivier Detry, Patrizio Lancellotti
Publikováno v:
BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Infectious Diseases
BMC Infectious Diseases
Background There are limited data on Coronavirus disease 2019 (COVID-19) in solid organ transplant patients, especially in heart transplant recipients, with only a few case reports and case series described so far. Heart transplant recipients may be
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Infectious Diseases
BMC Infectious Diseases
Background Treatment of chronic hepatitis C virus infection with direct acting antiviral therapy results in viral elimination in over 90% of cases. The duration of treatment required to achieve cure differs between individuals and relapse can occur.